Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
posted on
Jun 13, 2023 08:21AM
PS...
And the fact that some of our best and brightest minds on this board like Bear and Kelsey and others too all of whom are so knowledgeable, and all of whom have also seemingly moved on is equally telling...